There is no medically approved or officially recommended IV drip for skin whitening
Through MAPK and PI3K signaling, Tat further elevates chemokines: ERK1/2 and PI3K increase CCL2 and CCL4
Contact your GP, healthcare provider, or if you need urgent advice NHS 111 if you experience: A persistent resting heart rate above 100 bpm (resting tachycardia) Palpitations a sensation of a racing, fluttering, or pounding heartbeat Dizziness, light-headedness, or near-fainting episodes Chest discomfort or tightness, particularly if associated with exertion Shortness of breath that is new or worsening Fatigue that is disproportionate to your level of activity Seek emergency medical attention (call 999 or go to A&E) if you experience: Chest pain radiating to the arm, jaw, or back Sudden severe breathlessness Loss of consciousness or collapse A very rapid or irregular heartbeat that does not settle within a few minutes Some symptoms, such as mild palpitations or a sensation of a faster heartbeat, may be transient and occur particularly after dose escalation
The medications pharmacokinetics allow for once-weekly dosing, and research continues to evaluate long-term cardiovascular outcomes
Lead to human trials if the mechanisms prove robust enough
